D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
THC holding history
Tenet Healthcare Corp in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
THC overviewAll 13F holders of THCFull Q2 2026 holdings
- Shares (Q2 2026)
- 30,397
- Value
- $5.69M
- % of portfolio
- <0.1%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 30,397 | $5.69M | <0.1% | −229,672−88.3% | Reduced | Holders |
| Q1 2026 | 260,069 | $49.1M | <0.1% | −929,443−78.1% | Reduced | Holders |
| Q4 2025 | 1,189,512 | $236.4M | 0.2% | +444,616+59.7% | Added | Holders |
| Q3 2025 | 744,896 | $151.2M | 0.1% | −63,358−7.8% | Reduced | Holders |
| Q2 2025 | 808,254 | $142.3M | 0.1% | +79,990+11.0% | Added | Holders |
| Q1 2025 | 728,264 | $98.0M | 0.1% | −288,373−28.4% | Reduced | Holders |
| Q4 2024 | 1,016,637 | $128.3M | 0.1% | +967,567+1,971.8% | Added | Holders |
| Q3 2024 | 49,070 | $8.16M | <0.1% | +2,542+5.5% | Added | Holders |
| Q2 2024 | 46,528 | $6.19M | <0.1% | −10,686−18.7% | Reduced | Holders |
| Q1 2024 | 57,214 | $6.01M | <0.1% | −33,400−36.9% | Reduced | Holders |
| Q4 2023 | 90,614 | $6.85M | <0.1% | −119,849−56.9% | Reduced | Holders |
| Q3 2023 | 210,463 | $13.9M | <0.1% | −130,472−38.3% | Reduced | Holders |
| Q2 2023 | 340,935 | $27.7M | <0.1% | −85,801−20.1% | Reduced | Holders |
| Q1 2023 | 426,736 | $25.4M | <0.1% | −688,478−61.7% | Reduced | Holders |
| Q4 2022 | 1,115,214 | $54.4M | 0.1% | +1,047,814+1,554.6% | Added | Holders |
| Q3 2022 | 67,400 | $3.48M | <0.1% | +47,487+238.5% | Added | Holders |
| Q2 2022 | 19,913 | $1.05M | <0.1% | +16,617+504.2% | Added | Holders |
| Q1 2022 | 3,296 | $283.0K | <0.1% | −8,606−72.3% | Reduced | Holders |
| Q4 2021 | 11,902 | $972.0K | <0.1% | −33,432−73.7% | Reduced | Holders |
| Q3 2021 | 45,334 | $3.01M | <0.1% | −44,262−49.4% | Reduced | Holders |
| Q2 2021 | 89,596 | $6.00M | <0.1% | −56,715−38.8% | Reduced | Holders |
| Q1 2021 | 146,311 | $7.61M | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.